Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
1,022,530
-
Total 13F shares
-
1,079,250
-
Share change
-
+367,936
-
Total reported value
-
$386,791
-
Price per share
-
$0.36
-
Number of holders
-
19
-
Value change
-
+$131,804
-
Number of buys
-
8
-
Number of sells
-
5
Institutional Holders of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) as of Q4 2024
As of 31 Dec 2024,
Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,079,250 shares.
The largest 10 holders included
AdvisorShares Investments LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Virtu Financial LLC, TWO SIGMA SECURITIES, LLC, XTX Topco Ltd, VANGUARD GROUP INC, CITADEL ADVISORS LLC, TWO SIGMA INVESTMENTS, LP, and JANE STREET GROUP, LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.